Digital Marketing Trends in Type 2 Diabetes
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Digital Marketing Trends in Type 2 Diabetes Report Overview
Novo Nordisk’s Ozempic.com achieved the highest total traffic across branded type 2 diabetes (T2D) patient sites in the US, from April 2023 to March 2024. This was followed by Rybelsus.com. Overall, the highest proportion of traffic to top branded patient T2D websites originated from direct sources, followed by organic sources. There were a few branded sites in the five major European markets (5EU: France, Germany, Italy, Spain, UK) and Canada (EUCAN) that had detectable traffic.
Buy the Full Report to get More Insights into the Digital Marketing Trends in Type 2 Diabetes
Download a Free Report Sample
The ‘Digital Marketing Trends in Type 2 Diabetes’ report provides an analysis of key digital marketing metrics of pharma assets in T2D, including branded websites for patients and HCPs and unbranded websites. Furthermore, the report enlists metrics such as website traffic volume, engagement, source, DDA, and paid SEO.
| Key US Branded Websites for Patients | · Novo Nordisk’s Ozempic.com
· Novo Nordisk’s Rybelsus.com · Eli Lily’s Mounjaro.com · AstraZeneca’s Farxiga.com · Eli Lily/Boehringer Ingelheim’s Jardiance.com |
| Key US Branded HCP Websites for Type 2 Diabetes | · Novo Nordisk’s Novomedlink.com
· AstraZeneca’s Farxiga-hcp.com · Sanofi’s Toujeopro.com |
| Key Us Unbranded Websites for Type 2 Diabetes | · Novo Nordisk’s Getrealaboutdiabetes.com
· Sanofi’s Teamingupfordiabetes.com · Novo Nordisk’s Diabeteseducation.novocare.com |
| Key EUCAN Branded Websites for Type 2 Diabetes | · Novo Nordisk’s Rybelsus.ca
· Novo Nordisk’s Tresiba.ca |
| Key EUCAN Unbranded Websites for Type 2 Diabetes | · Novo Nordisk’s Diabete.fr
· AstraZeneca’s Zuckerkrank.de · Sanofi’s Sanofi-diabete.fr |
| Enquire & Decide |
Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Key US Branded Patient Websites for Type 2 Diabetes
The key US-branded patient websites for type 2 diabetes are Novo Nordisk’s Ozempic.com, Novo Nordisk’s Rybelsus.com, Eli Lily’s Mounjaro.com, AstraZeneca’s Farxiga.com, and Eli Lily/Boehringer Ingelheim’s Jardiance.com, among others. Novo Nordisk’s Ozempic.com achieved the highest traffic from April 2023 to March 2024 across T2D patient sites in the US, followed by Novo Nordisk’s Rybelsus.com.
Digital Marketing Trends in Type 2 Diabetes Analysis by US Branded Patient Websites, April 2023- March 2024
Buy the Full Report to Get More Insights into the US Branded Patient Websites for Type 2 Diabetes
Download a Free Report Sample
Key US Branded HCP Websites for Type 2 Diabetes
The key US-branded HCP websites for type 2 diabetes are Novo Nordisk’s Novomedlink.com, AstraZeneca’s Farxiga-hcp.com, and Sanofi’s Toujeopro.com. Novo Nordisk’s Novomedlink.com achieved the highest traffic across T2D HCP sites in the US from April 2023 to March 2024.
Digital Marketing Trends in Type 2 Diabetes Analysis by US Branded HCP Websites, April 2023- March 2024
Buy the Full Report to Get More Insights into the US Branded HCP Websites for Type 2 Diabetes
Download a Free Report Sample
Key US Unbranded Websites for Type 2 Diabetes
The key US-unbranded websites for type 2 diabetes are Novo Nordisk’s Getrealaboutdiabetes.com, Sanofi’s Teamingupfordiabetes.com, and Novo Nordisk’s Diabeteseducation.novocare.com. Novo Nordisk’s Diabeteseducation.novocare.com achieved the highest traffic from April 2023 to March 2024 across T2D unbranded sites in the US, followed by Sanofi’s Teamingupfordiabetes.com.
Digital Marketing Trends in Type 2 Diabetes Analysis by US Unbranded Websites, April 2023- March 2024
Buy the Full Report to Get More Insights into the US Unbranded Websites for Type 2 Diabetes
Download a Free Report Sample
Key EUCAN Branded Websites for Type 2 Diabetes
The key EUCAN-branded websites for T2D are Novo Nordisk’s Rybelsus.ca and Novo Nordisk’s Tresiba.ca. Novo Nordisk’s Rybelsus.ca achieved the highest traffic across T2D-branded sites in the EUCAN between April 2023 and March 2024.
Digital Marketing Trends in Type 2 Diabetes Analysis by EUCAN Branded Websites, April 2023- March 2024
Buy the Full Report to Get More Insights into the EUCAN Branded Websites for Type 2 Diabetes
Download a Free Report Sample
Key EUCAN Unbranded Websites for Type 2 Diabetes
The key EUCAN unbranded websites for type 2 diabetes are Novo Nordisk’s Diabete.fr, AstraZeneca’s Zuckerkrank.de, and Sanofi’s Sanofi-diabete.fr. Novo Nordisk’s Diabete.fr achieved the highest traffic across T2D-unbranded sites in the EUCAN between April 2023 and March 2024.
Digital Marketing Trends in Type 2 Diabetes Analysis by EUCAN Unbranded Websites, April 2023- March 2024
Buy the Full Report to Get More Insights into the EUCAN Unbranded Websites for Type 2 Diabetes
Download a Free Report Sample
Scope
This report assesses key digital marketing metrics of pharma assets in T2D including branded websites for patients and HCPs and unbranded sites.
Metrics include website traffic volume, engagement, and source, DDA and paid SEO.
Countries include the US and EUCAN.
Reasons to Buy
- Understand the digital marketing competitive landscape in T2D, with a view of leading patient and HCP branded assets across different regions.
- See what tactics pharma companies are using to drive traffic to their T2D branded assets for patient and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded and unbranded assets for patients by how they address and support different patient needs.
Table of Contents
Frequently asked questions
-
Which are the key US-branded patient websites for type 2 diabetes?
The key US-branded patient websites for type 2 diabetes are Novo Nordisk’s Ozempic.com, Novo Nordisk’s Rybelsus.com, Eli Lily’s Mounjaro.com, AstraZeneca’s Farxiga.com, and Eli Lily/Boehringer Ingelheim’s Jardiance.com, among others.
-
Which are the key US-branded HCP websites for type 2 diabetes?
The key US-branded HCP websites for type 2 diabetes are Novo Nordisk’s Novomedlink.com, AstraZeneca’s Farxiga-hcp.com, and Sanofi’s Toujeopro.com.
-
Which website achieved the highest traffic across T2D HCP sites in the US from April 2023 to March 2024?
Novo Nordisk’s Novomedlink.com achieved the highest traffic across T2D HCP sites in the US from April 2023 to March 2024.
-
Which are the key EUCAN-branded websites for type 2 diabetes?
The key EUCAN-branded websites for type 2 diabetes are Novo Nordisk’s Rybelsus.ca and Novo Nordisk’s Tresiba.ca.
-
Which are the key EUCAN-unbranded websites for type 2 diabetes?
The key EUCAN unbranded websites for type 2 diabetes are Novo Nordisk’s Diabete.fr, AstraZeneca’s Zuckerkrank.de, and Sanofi’s Sanofi-diabete.fr.
-
Which website achieved the highest traffic across T2D-unbranded sites in the EUCAN between April 2023 and March 2024?
Novo Nordisk’s Diabete.fr achieved the highest traffic across T2D-unbranded sites in the EUCAN between April 2023 and March 2024.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Type 2 Diabetes reports




